These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 39398012)

  • 1. Deciphering miRNA signatures in axial spondyloarthritis: The link between miRNA-1-3p and pro-inflammatory cytokines.
    Prokopcova A; Baloun J; Bubova K; Gregova M; Forejtova S; Horinkova J; Husakova M; Mintalova K; Cervenak V; Tomcik M; Vencovsky J; Pavelka K; Senolt L
    Heliyon; 2024 Oct; 10(19):e38250. PubMed ID: 39398012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
    Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
    Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
    Levitova A; Hulejova H; Spiritovic M; Pavelka K; Senolt L; Husakova M
    Arthritis Res Ther; 2016 Nov; 18(1):275. PubMed ID: 27887637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis.
    Prajzlerová K; Grobelná K; Hušáková M; Forejtová Š; Jüngel A; Gay S; Vencovský J; Pavelka K; Šenolt L; Filková M
    PLoS One; 2017; 12(9):e0185323. PubMed ID: 28938006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of microRNAs in peripheral blood mononuclear cells as candidate biomarkers in patients with axial spondyloarthritis.
    Li X; Lv Q; Tu L; Zhao M; Zhang P; Li Q; Wei Q; Cao S; Gu J
    Int J Rheum Dis; 2019 Jul; 22(7):1188-1195. PubMed ID: 30990253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of active inflammation, chronic structural damage, and response to treatment of sacroiliitis in axial spondyloarthritis using the Spondyloarthritis research consortium of Canada scoring system.
    Zhang Y; Guo Z; Zhan Y; Qu J; Lei X
    BMC Musculoskelet Disord; 2022 Jul; 23(1):654. PubMed ID: 35804360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
    Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
    Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials.
    van der Heijde D; Deodhar A; Baraliakos X; Brown MA; Dobashi H; Dougados M; Elewaut D; Ellis AM; Fleurinck C; Gaffney K; Gensler LS; Haroon N; Magrey M; Maksymowych WP; Marten A; Massow U; Oortgiesen M; Poddubnyy D; Rudwaleit M; Shepherd-Smith J; Tomita T; Van den Bosch F; Vaux T; Xu H
    Ann Rheum Dis; 2023 Apr; 82(4):515-526. PubMed ID: 36649967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum visfatin levels in patients with axial spondyloarthritis and their relationship to disease activity and spinal radiographic damage: a cross-sectional study.
    Hulejová H; Kropáčková T; Bubová K; Kryštůfková O; Filková M; Mann H; Forejtová Š; Tomčík M; Vencovský J; Pavelka K; Šenolt L
    Rheumatol Int; 2019 Jun; 39(6):1037-1043. PubMed ID: 31025138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence.
    Braun J; Kiltz U; Bühring B; Baraliakos X
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X211041854. PubMed ID: 34471428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of plasma microRNA potentials as a non-invasive biomarker in patients with axial spondyloarthropathy.
    Yildirim T; Yesilada E; Eren F; Apaydin H; Gulbay G
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):620-625. PubMed ID: 33577015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy.
    Robinson PC; Sengupta R; Siebert S
    Rheumatol Ther; 2019 Jun; 6(2):165-177. PubMed ID: 30788779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis.
    Braun J; Baraliakos X; Hermann KG; Landewé R; Machado PM; Maksymowych WP; Davies O; Hoepken B; Nurminen T; Stach C; van der Heijde D
    RMD Open; 2017; 3(1):e000430. PubMed ID: 28848654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study.
    Burgos-Varga R; Wei JC; Rahman MU; Akkoc N; Haq SA; Hammoudeh M; Mahgoub E; Singh E; Llamado LJ; Shirazy K; Kotak S; Hammond C; Pedersen R; Shen Q; Vlahos B
    Arthritis Res Ther; 2016 Jun; 18(1):132. PubMed ID: 27267875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort.
    Hebeisen M; Micheroli R; Scherer A; Baraliakos X; de Hooge M; van der Heijde D; Landewé R; Bürki K; Nissen MJ; Möller B; Zufferey P; Exer P; Ciurea A
    PLoS One; 2020; 15(3):e0230268. PubMed ID: 32196530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial.
    van der Heijde D; Baraliakos X; Hermann KA; Landewé RBM; Machado PM; Maksymowych WP; Davies OR; de Peyrecave N; Hoepken B; Bauer L; Nurminen T; Braun J
    Ann Rheum Dis; 2018 May; 77(5):699-705. PubMed ID: 29343510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiographic progression in non-radiographic axial spondyloarthritis.
    Protopopov M; Poddubnyy D
    Expert Rev Clin Immunol; 2018 Jun; 14(6):525-533. PubMed ID: 29774755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
    Burmester GR; Stigler J; Rubbert-Roth A; Tanaka Y; Azevedo VF; Coombs D; Lagunes I; Lippe R; Wung P; Gensler LS
    Rheumatol Ther; 2024 Jun; 11(3):737-753. PubMed ID: 38683479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
    Malaviya AN; Kalyani A; Rawat R; Gogia SB
    Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.